C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor

The acute inflammatory response is frequently accompanied by serious thrombotic events. We show that C-reactive protein (CRP), an acute- phase reactant that markedly increases its serum concentration in response to inflammatory stimuli, induced monocytes to express tissue factor (TF), a potent procoagulant. Purified human CRP in concentrations commonly achieved in vivo during inflammation (10 to 100 micrograms/mL) induced a 75-fold increase in TF procoagulant activity (PCA) of human peripheral blood mononuclear cells (PBM), with a parallel increase in TF antigen levels. CRP-induced PCA was completely blocked by a monoclonal antibody against human TF but not by irrelevant murine IgG. Dot blot analysis showed a significant increase of TF mRNA after 4 hours of incubation with CRP, followed by a peak of PCA within 6 and 8 hours. Actinomycin D and cycloheximide blocked CRP-stimulated PCA, suggesting that de novo TF protein synthesis was required. Endotoxin (LPS) contamination of CRP was excluded as the mediator of TF synthesis because: (1) CRP was Limulus assay negative; (2) induction of TF PCA by CRP was not blocked by Polymyxin B, in contrast to LPS- induced PCA; (3) antihuman CRP IgG inhibited CRP-induced PCA, but not LPS-induced PCA; (4) CRP was able to stimulate TF production in LPS- pretreated PBM refractory to additional LPS stimulation; and, (5) unlike LPS, CRP was incapable of inducing TF in human umbilical vein endothelial cells. We suggest that CRP-mediated TF production in monocytes may contribute to the development of disseminated intravascular coagulation and thrombosis in inflammatory states.

[1]  J. Weinberg,et al.  Tumor necrosis factor induces tissue factor-like activity in human leukemia cell line U937 and peripheral blood monocytes. , 1988, Blood.

[2]  N. Mackman,et al.  Cellular immune and cytokine pathways resulting in tissue factor expression and relevance to septic shock. , 1992, Nouvelle revue francaise d'hematologie.

[3]  J. Tebo,et al.  Characterization and isolation of a C-reactive protein receptor from the human monocytic cell line U-937. , 1990, Journal of immunology.

[4]  A. Guha,et al.  An inhibitory monoclonal antibody against human tissue factor. , 1987, Blood.

[5]  H. Prydz,et al.  Differential effect of alpha-interferon and gamma-interferon on thromboplastin response in monocytes and endothelial cells. , 1987, Clinical and experimental immunology.

[6]  J. Miletich,et al.  [18] Purification of human coagulation factors II, IX, and X using sulfated dextran beads , 1981 .

[7]  M. Urowitz,et al.  Monocyte procoagulant activity in glomerulonephritis associated with systemic lupus erythematosus. , 1985, The Journal of clinical investigation.

[8]  J. Sadler,et al.  Regulation of endothelial cell coagulant properties. Modulation of tissue factor, plasminogen activator inhibitors, and thrombomodulin by phorbol 12-myristate 13-acetate and tumor necrosis factor. , 1989, The Journal of biological chemistry.

[9]  T. Flægstad,et al.  Increased Tissue Thromboplastin Activity in Monocytes of Patients with Meningococcal Infection: Related to an Unfavourable Prognosis , 1983, Thrombosis and Haemostasis.

[10]  D. Stern,et al.  Interleukin 1 induces endothelial cell procoagulant while suppressing cell-surface anticoagulant activity. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[11]  T. Edgington,et al.  Plasma lipoprotein induction and suppression of the generation of cellular procoagulant activity in vitro. , 1981, The Journal of clinical investigation.

[12]  M. Pepys C-REACTIVE PROTEIN FIFTY YEARS ON , 1981, The Lancet.

[13]  P. Majerus,et al.  Purification and characterization of human coagulation factor V. , 1981, The Journal of biological chemistry.

[14]  A. Marcus,et al.  Enhancement of mononuclear procoagulant activity by platelet 12-hydroxyeicosatetraenoic acid. , 1986, The Journal of clinical investigation.

[15]  T. Lyberg,et al.  Effect of immune complex-containing sera from patients with rheumatic diseases on thromboplastin activity of monocytes. , 1982, Thrombosis research.

[16]  J. Filep,et al.  C‐reactive protein inhibits intracellular calcium mobilization and superoxide production by guinea pig alveolar macrophages , 1992, Journal of leukocyte biology.

[17]  R. Rivers,et al.  The Expression of Surface Tissue Factor Apoprotein by Blood Monocytes in the Course of Infections in Early Infancy , 1992, Pediatric Research.

[18]  W. Konigsberg,et al.  Tumor necrosis factor enhances expression of tissue factor mRNA in endothelial cells. , 1989, Thrombosis research.

[19]  J. Volanakis,et al.  Interaction of C-reactive protein complexes with the complement system. I. Consumption of human complement associated with the reaction of C-reactive protein with pneumococcal C-polysaccharide and with the choline phosphatides, lecithin and sphingomyelin. , 1974, Journal of immunology.

[20]  J. Vaughan,et al.  Leukocyte procoagulant activity: enhancement of production in vitro by IgG and antigen-antibody complexes. , 1977, The Journal of clinical investigation.

[21]  R. Anderson,et al.  Neutrophil lysosomal degradation of human CRP: CRP-derived peptides modulate neutrophil function. , 1988, Clinical and experimental immunology.

[22]  B. Osterud,et al.  Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[23]  P. D. Rick,et al.  Structural features of Salmonella typhimurium lipopolysaccharide required for activation of tissue factor in human mononuclear cells. , 1977, The Journal of clinical investigation.

[24]  J. Tebo,et al.  Internalization and degradation of receptor bound C-reactive protein by U-937 cells: induction of H2O2 production and tumoricidal activity. , 1991, Biochimica et biophysica acta.

[25]  R. Miserez,et al.  LPS-induced, but not interferon-gamma-induced procoagulant activity of suspended human macrophages is followed by a refractory state of low procoagulant expression. , 1992, Thrombosis research.

[26]  G. Lozanski,et al.  Induction of inflammatory cytokine release from cultured human monocytes by C-reactive protein. , 1992, Cytokine.

[27]  T. Lint,et al.  Enhancement of Human Peripheral Blood Monocyte Respiratory Burst Activity by Aggregated C‐Reactive Protein , 1986, Journal of leukocyte biology.

[28]  A. Mantovani,et al.  Induction of monocyte-macrophage procoagulant activity by transformed cell lines. , 1986, Journal of immunology.

[29]  Y. Nemerson,et al.  Factor VII binding to tissue factor in reconstituted phospholipid vesicles: induction of cooperativity by phosphatidylserine. , 1986, Biochemistry.

[30]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[31]  D. Schultz,et al.  Properties of four acute phase proteins: C-reactive protein, serum amyloid A protein, alpha 1-acid glycoprotein, and fibrinogen. , 1990, Seminars in arthritis and rheumatism.

[32]  T. Edgington,et al.  Plasma lipoprotein induction and suppression of the generation of cellular procoagulant activity in vitro: two procoagulant activities are produced by peripheral blood mononuclear cells. , 1981, The Journal of clinical investigation.

[33]  H. Gewurz Biology of C-reactive protein and the acute phase response. , 1982, Hospital practice.

[34]  K. Zahedi,et al.  Macrophage tumoricidal activity induced by human C-reactive protein. , 1986, Cancer research.

[35]  K. Williams,et al.  Isolation of cDNA clones coding for human tissue factor: primary structure of the protein and cDNA. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[36]  H. Gewurz,et al.  Characterization of C-reactive protein and the complement subcomponent C1t as homologous proteins displaying cyclic pentameric symmetry (pentraxins). , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[37]  C. Mariash,et al.  Loading and transfer control for Northern hybridization. , 1992, BioTechniques.

[38]  P. Spagnuolo,et al.  Binding of C-reactive protein to human neutrophils. Inhibition of respiratory burst activity. , 1991, Arthritis and rheumatism.

[39]  R. Bach Initiation of Coagulation by Tissue Facto , 1988 .

[40]  P. Majerus,et al.  Purification and properties of human coagulation factor VII. , 1980, The Journal of biological chemistry.

[41]  E. Nicodème,et al.  Refractory period phenomenon in the induction of tissue factor expression on endothelial cells. , 1991, Blood.

[42]  A. Allison,et al.  Tissue Thromboplastin Activity of Isolated Human Monocytes , 1978, Thrombosis and Haemostasis.

[43]  E. Downs,et al.  Modulation of human monocyte chemotaxis and procoagulant activity by human C-reactive protein (CRP). , 1986, Lymphokine research.

[44]  W. Konigsberg,et al.  Serum stimulation of quiescent human fibroblasts induces the synthesis of tissue factor mRNA followed by the appearance of tissue factor antigen and procoagulant activity , 1989, Journal of cellular physiology.

[45]  E. Jaffe,et al.  Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. , 1973, The Journal of clinical investigation.

[46]  W. Weston,et al.  The Endotoxin‐induced Coagulant Activity of Human Monocytes , 1975, British journal of haematology.